Skip to main content

Advertisement

Log in

Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Data from several case–control studies on the relation between the Cyclin D1 (CCND1) G870A polymorphism and oral cancer susceptibility implicated conflicting conclusions. Thus, a meta-analysis was performed to derive a more precise evaluation of the association. We searched PubMed and Embase for related studies that had been published in English and eight available studies were finally included in the meta-analysis. Odd ratios (ORs) and 95 % confidence intervals (CIs) were calculated for each study. Our meta-analysis suggested that CCND1 G870A polymorphism was not associated with oral cancer risk (OR AA vs. GG = 1.08, 95 % CI = 0.90–1.30, P heterogeneity = 0.175; OR AA + GA vs. GG = 1.02, 95 % CI = 0.91–1.14, P heterogeneity = 0.781; OR AA vs. GA + GG = 1.16, 95 % CI = 0.98–1.36, P heterogeneity = 0.107; OR A vs. G = 1.05 95 % CI = 0.96–1.15, P heterogeneity = 0.211; OR GA vs. GG = 0.94, 95 % CI = 0.82–1.08, P heterogeneity = 0.935). However, in the subgroup analysis by ethnicity, possible significance among Asian groups was indicated in two genetic models (OR AA vs. GA + GG = 1.27, 95 % CI = 1.05–1.54, P heterogeneity = 0.572; OR allele A vs. allele G = 1.11, 95 % CI = 1.00–1.24, P heterogeneity = 0.211). Taken together, the meta-analysis revealed that CCND1 G870A polymorphism might be correlated with the susceptibility of oral cancer in Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Akkiz H, Bayram S, Bekar A, Akgollu E, Ozdil B. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case–control study. Cancer Epidemiol. 2010;34(3):298–302.

    Article  CAS  PubMed  Google Scholar 

  2. Balcerczak E, Pasz-Walczak G, Kumor P, Panczyk M, Kordek R, Wierzbicki R, et al. Cyclin D1 protein and CCND1 gene expression in colorectal cancer. Eur J Surg Oncol J Eur Soc Surg Oncol B Assoc Surg Oncol. 2005;31(7):721–6.

    CAS  Google Scholar 

  3. Bizari L, Borim AA, Leite KR, Goncalves Fde T, Cury PM, Tajara EH, et al. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genet Cytogenet. 2006;165(1):41–50.

    Article  CAS  PubMed  Google Scholar 

  4. Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, et al. CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res. 2010;30(7):3093–8.

    CAS  PubMed  Google Scholar 

  5. Caplan DJ, Hertz-Picciotto I. Racial differences in survival of oral and pharyngeal cancer patients in North Carolina. J Public health Dent. 1998;58(1):36–43.

    Article  CAS  PubMed  Google Scholar 

  6. Ceschi M, Sun CL, Van Den Berg D, Koh WP, Yu MC, Probst-Hensch N. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis. 2005;26(8):1457–64.

    Article  CAS  PubMed  Google Scholar 

  7. Cui J, Shen L, Wang Y. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls. Asian Pac J Cancer Prev APJCP. 2012;13(10):5023–5.

    Article  Google Scholar 

  8. Franceschi S, Talamini R, Barra S, Baron AE, Negri E, Bidoli E, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res. 1990;50(20):6502–7.

    CAS  PubMed  Google Scholar 

  9. Gomes CC, Drummond SN, Guimaraes AL, Andrade CI, Mesquita RA, Gomez RS. P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2008;37(3):151–6.

    Article  CAS  Google Scholar 

  10. Holley SL, Matthias C, Jahnke V, Fryer AA, Strange RC, Hoban PR. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol. 2005;41(2):156–60.

    Article  CAS  PubMed  Google Scholar 

  11. Liao CT, Wang HM, Ng SH, Yen TC, Lee LY, Hsueh C, et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol. 2006;42(8):800–9.

    Article  PubMed  Google Scholar 

  12. Liu W, Zhu E, Wang R, Wang L, Gao L, Yang X, et al. Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population. Cancer Epidemiol. 2011;35(4):e12–7.

    Article  CAS  PubMed  Google Scholar 

  13. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res. 2003;63(21):7056–61.

    CAS  PubMed  Google Scholar 

  14. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J, et al. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res Off J Am Assoc Cancer Res. 1998;4(10):2411–8.

    CAS  Google Scholar 

  15. Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR. Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn health. 2001;6(3–4):165–77.

    Article  CAS  PubMed  Google Scholar 

  16. Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, Simpson AJ, Caballero OL, et al. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol. 2004;40(6):604–10.

    Article  CAS  PubMed  Google Scholar 

  17. Noel EE, Yeste-Velasco M, Mao X, Perry J, Kudahetti SC, Li NF, et al. The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers. Am J Pathol. 2010;176(6):2607–15.

    Article  CAS  PubMed  Google Scholar 

  18. Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol. 2006;42(6):607–13.

    Article  CAS  PubMed  Google Scholar 

  19. Sherr CJ. D-type cyclins. Trends Biochem Sci. 1995;20(5):187–90.

    Article  CAS  PubMed  Google Scholar 

  20. Sherr CJ. Cancer cell cycles. Science. 1996;274(5293):1672–7.

    Article  CAS  PubMed  Google Scholar 

  21. Shiboski CH, Shiboski SC, Silverman Jr S. Trends in oral cancer rates in the United States, 1973–1996. Community Dent Oral Epidemiol. 2000;28(4):249–56.

    Article  CAS  PubMed  Google Scholar 

  22. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, et al. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem. 2003;278(32):30339–47.

    Article  CAS  PubMed  Google Scholar 

  23. Sutherland RL, Musgrove EA. Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models. Breast Cancer Res BCR. 2002;4(1):14–7.

    Article  CAS  Google Scholar 

  24. Swango PA. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public health Dent. 1996;56(6):309–18.

    Article  CAS  PubMed  Google Scholar 

  25. Tsai MH, Tsai CW, Tsou YA, Hua CH, Hsu CF, Bau DT. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in Taiwan. Anticancer Res. 2011;31(1):227–31.

    CAS  PubMed  Google Scholar 

  26. Wang L, Habuchi T, Mitsumori K, Li Z, Kamoto T, Kinoshita H, et al. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. Int J Cancer J Int Cancer. 2003;103(1):116–20.

    Article  CAS  Google Scholar 

  27. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, Kakehi Y, et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis. 2002;23(2):257–64.

    Article  PubMed  Google Scholar 

  28. Wang W, Zhao Y, Yang J, Lin B, Gu H, Cao X, et al. Cyclin D1 polymorphism and oral cancer: a meta-analysis. Mol Biol Rep. 2013;40(1):87–95.

    Article  CAS  PubMed  Google Scholar 

  29. Wong YK, Lin SC, Chang CS, Tseng YH, Liu CJ, Lin HC, et al. Cyclin D1 genotype in areca-associated oral squamous cell carcinoma. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2003;32(5):265–70.

    Article  CAS  Google Scholar 

  30. Zhuo XL, Ling JJ, Zhao HY, Zhou Y, Song YF, Tan YH. Lack of association of the cyclin D1 G870A variation with oral carcinoma risk: Evidence from 2,404 subjects. Exp Ther Med. 2012;4(4):748–54.

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Funding

This work was supported by Liaoning Medical University Youth Science and Technology Foundation (no. Y2012Z008), Liaoning Foundation of Education Department (no. L2012309), Liaoning Natural Science Fund Project (no. 20102135), and Liaoning Natural Science Fund Project of Science and Technology (no. 2013022029).

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhiying Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, L., Wang, Z., Gao, X. et al. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis. Tumor Biol. 35, 1149–1155 (2014). https://doi.org/10.1007/s13277-013-1154-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1154-8

Keywords

Navigation